122 related articles for article (PubMed ID: 1876573)
1. Pharmacokinetics of ursodeoxycholic acid in rat.
Roda A; Hrelia P; Paolini M; Calzolari M; Grigolo B; Simoni P; Aldini R; Forti GC
Pharmacol Res; 1991 May; 23(4):327-35. PubMed ID: 1876573
[TBL] [Abstract][Full Text] [Related]
2. Bile acids with a cyclopropyl-containing side chain. IV. Physicochemical and biological properties of the four diastereoisomers of 3 alpha,7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid.
Roda A; Grigolo B; Aldini R; Simoni P; Pellicciari R; Natalini B; Balducci R
J Lipid Res; 1987 Dec; 28(12):1384-97. PubMed ID: 3430066
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats.
Ventura P; Panini R; Montosi G; Garuti C; Vandelli M; Brunetti G; Tauschel H; Pietrangelo A; Salvioli G
Pharmacology; 2001 Feb; 62(2):107-12. PubMed ID: 11174081
[TBL] [Abstract][Full Text] [Related]
4. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
[TBL] [Abstract][Full Text] [Related]
5. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
[TBL] [Abstract][Full Text] [Related]
6. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
7. Permeability of the rat biliary tree to ursodeoxycholic acid.
Farges O; Corbic M; Dumont M; Maurice M; Erlinger S
Am J Physiol; 1989 Apr; 256(4 Pt 1):G653-60. PubMed ID: 2705526
[TBL] [Abstract][Full Text] [Related]
8. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters.
Handelsman B; Bonorris G; Marks JW; Schoenfield LJ
Am J Physiol; 1982 Nov; 243(5):G424-7. PubMed ID: 7137357
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of total serum bile acids concentration and bile acid profiles in healthy cats after oral administration of ursodeoxycholic acid.
Day DG; Meyer DJ; Johnson SE; Weisbrode SE; Thudium DT; Rhodes DC
Am J Vet Res; 1994 Oct; 55(10):1474-8. PubMed ID: 7998707
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
Renner EL; Lake JR; Cragoe EJ; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1988 Feb; 254(2 Pt 1):G232-41. PubMed ID: 2831731
[TBL] [Abstract][Full Text] [Related]
11. Regurgitation of bile acids in rat liver under bile drainage: quantitative analysis by taurine or ursodeoxycholate loading test.
Nakashima T; Nakagawa Y; Sano A; Sakamoto Y; Shima T; Nakajima T; Seto Y; Okuno T; Kashima K
J Gastroenterol Hepatol; 1990; 5(2):121-5. PubMed ID: 2103392
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.
Walker S; Rudolph G; Raedsch R; Stiehl A
Gastroenterology; 1992 Mar; 102(3):810-5. PubMed ID: 1537519
[TBL] [Abstract][Full Text] [Related]
13. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
Yanaura S; Izuka A; Ishikawa S
Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and metabolism of [14C]ursodeoxycholic acid in the rat.
Parquet M; Rey C; Groussard M; Infante R
Biochim Biophys Acta; 1981 Aug; 665(2):299-305. PubMed ID: 7284427
[TBL] [Abstract][Full Text] [Related]
15. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
Scharschmidt BF; Lake JR
Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
[TBL] [Abstract][Full Text] [Related]
17. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
[TBL] [Abstract][Full Text] [Related]
18. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
19. Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat.
Rodríguez-Ortigosa CM; Banales JM; Olivas I; Uriarte I; Marín JJ; Corrales FJ; Medina JF; Prieto J
Hepatology; 2010 Aug; 52(2):667-77. PubMed ID: 20683964
[TBL] [Abstract][Full Text] [Related]
20. Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.
Lake JR; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1987 Feb; 252(2 Pt 1):G163-9. PubMed ID: 3826345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
